Core Viewpoint - China Biotechnology Services (08037.HK) has entered into a subscription agreement with Fucheng Holdings Limited for the issuance of convertible bonds totaling $35 million, equivalent to approximately HKD 272.3 million, with a conversion price set at HKD 0.66 per share, representing a discount of about 16.46% from the closing price of HKD 0.79 on the agreement date [1] Group 1 - The total principal amount of the convertible bonds is $35 million, which will result in a maximum issuance of approximately 413 million shares, accounting for about 42.28% of the total shares outstanding as of the announcement date [1] - The net proceeds from the issuance of the convertible bonds are expected to be approximately $33.9 million [1] - The company plans to allocate 47.6% of the net proceeds for repaying other loans' principal and interest [1] Group 2 - 25.8% of the net proceeds will be used for the development and construction of a network of boron neutron capture therapy centers for cancer treatment [1] - 5.7% of the net proceeds will be allocated for research and development costs [1] - 20.9% of the net proceeds will be utilized for general working capital purposes [1]

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds to unspecified investors, which is a significant step for its financing strategy [1] Group 1 - The approval is documented in the official notice with the reference number 证监许可〔2025〕2788号 [1] - The company is required to implement the bond issuance strictly according to the submitted documents and issuance plan to the Shenzhen Stock Exchange [1] - The approval is valid for 12 months from the date of registration consent [1]

Core Viewpoint - The company has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified investors, pending further approval from regulatory authorities [1] Group 1 - The company received a notification on December 10, 2025, from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds [1] - The Shenzhen Stock Exchange has verified that the application documents submitted by the company are complete and has decided to accept the application [1] - The issuance of convertible bonds is subject to further review by the Shenzhen Stock Exchange and requires approval from the China Securities Regulatory Commission before implementation [1]

Core Viewpoint - CleanSpark plans to raise $1 billion through the issuance of zero-coupon convertible bonds to support its ongoing business expansion, despite experiencing a significant stock price decline of over 36% from its October peak [1] Group 1: Company Actions - The company intends to issue zero-coupon convertible bonds maturing in 2032 [1] - Up to $400 million of the raised funds will be allocated for stock buybacks [1] - Remaining funds will be used for expanding its power and land asset portfolio, building data center infrastructure, and debt repayment [1] Group 2: Market Reaction - CleanSpark's stock opened down over 8%, currently trading at $13.84 [1] - The stock has seen a significant decline of more than 36% from its high point in October [1]

Core Viewpoint - Shenyu Co., Ltd. has received approval from the Shenzhen Stock Exchange's Listing Review Committee for its application to issue convertible bonds to unspecified investors, pending registration with the China Securities Regulatory Commission (CSRC) [1][2]. Group 1: Convertible Bond Issuance - The company plans to raise a total of up to RMB 50 million through the issuance of convertible bonds, which will be fully allocated to the smart field data line construction project [1][2]. - The convertible bonds will have a term of six years from the date of issuance and will be convertible into the company's A-shares listed on the Shenzhen Stock Exchange [2][3]. Group 2: Shareholding Structure - As of the signing date of the fundraising prospectus, Ren Fengjuan holds 36,110,800 shares, accounting for 20.13% of the total shares, making her the controlling shareholder [3][4]. - The combined shareholding of Ren Fengjuan, her daughter Tang Xiaonan, and her husband Tang Jiankang amounts to 39.65% of the total shares, indicating significant influence over company decisions [3][4]. Group 3: Underwriting and Sponsorship - The lead underwriter for this bond issuance is Huatai United Securities Co., Ltd., with representatives Lü Fuxing and Li Jun overseeing the sponsorship [4].

Core Viewpoint - Dingjie Smart Co., Ltd. plans to issue convertible bonds to unspecified investors, with a total issuance amount not exceeding 827.6642 million yuan, subject to shareholder approval and regulatory review [2][15]. Group 1: Issuance Overview - The type of securities to be issued is convertible bonds that can be converted into the company's A-shares, which will be listed on the Shenzhen Stock Exchange [2]. - The total issuance scale is capped at 827.6642 million yuan, with the specific amount to be determined by the board of directors within this limit [2][15]. - Each bond will have a face value of 100 yuan and will be issued at face value [2]. - The bonds will have a maturity period of 6 years from the date of issuance [2]. Group 2: Interest and Repayment Terms - The bonds will pay interest annually, with the principal and final year's interest due at maturity [3]. - The interest calculation formula is defined as I = B × i, where I is the annual interest amount, B is the total face value held, and i is the annual coupon rate [3]. - The interest payment date will be the anniversary of the issuance date, with adjustments for holidays [4]. Group 3: Conversion and Redemption Terms - The conversion period for the bonds will start six months after issuance and end on the maturity date [4]. - The initial conversion price will be determined based on the average trading price of the company's shares prior to the announcement [4][5]. - The company reserves the right to redeem the bonds at face value plus accrued interest under certain conditions, such as if the stock price exceeds 130% of the conversion price for a specified period [9]. Group 4: Use of Proceeds - The net proceeds from the bond issuance will be used for specific investment projects, with a total planned investment of 1.151213 billion yuan, of which 827.6642 million yuan will be funded by the bond proceeds [15]. - The company will initially use self-raised funds for the projects until the bond proceeds are available [15]. Group 5: Financial Information - The financial reports for the years 2022, 2023, and 2024 have been audited, while the report for the first quarter of 2025 is unaudited [16]. - As of March 31, 2025, the company reported total assets of 333.8337 million yuan, with current assets amounting to 170.414 million yuan [18][19]. - The company’s total liabilities were reported at 102.1786 million yuan, with total equity of 231.655 million yuan [19].

Core Viewpoint - The company has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified investors, indicating a step forward in its financing strategy [1] Group 1 - The company received a notice from the Shenzhen Stock Exchange on August 14, 2025, regarding the acceptance of its application for issuing convertible bonds [1] - The Shenzhen Stock Exchange has verified that the application documents submitted by the company are complete and has decided to accept the application [1] - The issuance of the bonds is subject to further review by the Shenzhen Stock Exchange and requires approval from the China Securities Regulatory Commission before implementation, introducing uncertainty regarding the approval process and timeline [1]

Group 1 - The company proposes to issue HKD 88 billion convertible bonds at a price of HKD 17.32 per share with a coupon rate of 0.375% [1]